All Categories
Featured
Controlled Efficacy And Tolerability Study Of Oral Cannabidiol ... in Clearwater-Florida
Moreover, it is not completely understood whether these effects are related to CBD or to other...
Parkinson's Disease And Cannabis Research - Youtube in Paterson-New-Jersey
At low concentrations (sub-micromolar scale), CBD binds to equilibrative nucleoside transporter (ENT), transient receptor potential melastatin type...
Safety And Tolerability Of Cannabidiol In Parkinson Disease: An ... in Indianapolis-Indiana
Therefore, double-blind, placebo-controlled, randomized trials with larger samples of patients with PD are needed to elucidate the possible effectiveness and...
Cannabis Sativa And Cannabidiol: A Therapeutic Strategy For ... in New-Haven-Connecticut
An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from 150-400 mg/day,...
Cannabis Sativa And Cannabidiol: A Therapeutic Strategy For ... in Detroit-Michigan
At low concentrations (sub-micromolar scale), CBD binds to equilibrative nucleoside transporter (ENT), transient receptor potential melastatin type 8 (TRPM8), serotonin 1A receptor (5-HT1A), glycine receptors...
Parkinson's Patients To Receive Cannabidiol Treatment In ... in Greeley-Colorado
At low concentrations (sub-micromolar scale), CBD binds to equilibrative nucleoside transporter (ENT), transient receptor potential melastatin type 8 (TRPM8), serotonin 1A...
Safety And Tolerability Of Cannabidiol In Parkinson Disease in West-Jordan-Utah
Moreover, it is not completely understood whether these effects are related to CBD or to other organic compounds present in Cannabis extracts, such as...
Cbd Oil For Parkinson's Disease: Possible Treatment And ... in Hampton-Virginia
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular...
Effects Of Cannabidiol In The Treatment Of Patients With ... in Santa-Ana-California
The review goes from Cannabis sativa and its hundreds of bioactive compounds to Δ9-tetrahydrocannabinol (THC) and mainly cannabidiol (CBD) and...
The Era Of Once Weekly Continuous Drug Delivery For ... in El-Cajon-California
An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from 150-400 mg/day, combined with classic antiparkinsonian agents, reduced psychotic...
Navigation
Latest Posts
h
Medical Marijuana - Parkinson's Foundation in Durham-North-Carolina
Safety And Tolerability Of Natural And Synthetic Cannabinoids In ... in Thornton-Colorado
